How to reach us

Thuringian State Development Corporation (LEG Thüringen)

Mainzerhofstrasse 12 | 99084 Erfurt
Telephone: 0361 5603-0
Write an email

Personalized medicine: diagnostics, therapies and health strategies

Published: November 2025

Treating each person individually in the best possible way – that is the vision of personalized medicine. Technologies such as wearables, biosensors, and genetic analyses capture an individual's biological and lifestyle factors and derive tailored therapies. Advances in fields such as regenerative medicine, synthetic biology, and nanotechnology, in particular, expand the possibilities for customized treatments. In addition, AI and big data enable targeted health monitoring and preventative measures tailored to individual needs.

Guiding questions

  • How can the integration of AI and Big Data contribute to the prevention and early detection of chronic diseases?
  • How can Thuringia promote the development and application of personalized medicine?
  • What ethical and data protection measures are necessary to ensure the safe application of personalized medicine?
  • What options exist to ensure access to personalized healthcare solutions regardless of socioeconomic status?
  • What impact does the growing pressure of (self-)monitoring in the name of health have on patient autonomy?

challenges

The implementation of personalized medicine presents challenges in data protection and ethics, as handling sensitive data such as genetic information requires special protection. Complex regulatory requirements for new technologies like AI and genetic modification can also delay market launch. Furthermore, the high costs and resource intensity of innovative treatments, such as stem cell therapies and nanotechnology, are another obstacle hindering widespread application. In addition, the risk of social inequality in access to personalized healthcare solutions poses a health policy challenge.

Concrete examples

  • Precision diagnostics through wearables and biosensors
  • Regenerative medicine through 3D printing, e.g. of the body's own cartilage cells
  • Nanotechnology in cancer therapy

Foresight Report

Download

Reference

Your contact persons

Reference

Michel Reichardt

Michel Reichardt Project Manager Strategic Foresight

Christoph Grollman

Christoph Grollman Project Manager Strategic Foresight

Dr. Sophia Gänßle

Dr. Sophia Gänßle Project Manager Data Science Strategic Foresight

[linguise]